Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
This study has been terminated.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT01445340
First received: September 30, 2011
Last updated: May 3, 2013
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | No date given |